Common Contracts
1 similar Collaborative R&d Agreement contracts
Collaborative R&D agreement for regenerative medicine portfolioCollaborative R&d Agreement • June 16th, 2024
This agreement is an expansion of a long-standing collaboration which led to the development of C-Cure, Cardio3 BioSciences' product candidate now in advanced clinical trial testing (Phase III), an innovative cell therapy based on the discovery of the cardiopoiesis platform by the team at Mayo Clinic.
